Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | LDHB | P07195 | 1/20 | 0.36 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL5013666 | 1.00 | LMNA (0.40) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL167155 | 1.00 | LMNA (0.40) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL15968990 | 1.00 | LMNA (0.40) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL19614630 | 1.00 | LMNA (0.40) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL28395709 | 0.95 | LMNA (0.36) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL28773651 | 0.95 | LMNA (0.36) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL27705595 | 0.95 | LMNA (0.36) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL369561 | 0.95 | LMNA (0.44) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL2344232 | 0.95 | LMNA (0.44) | LMNATSHRTDP1CA1CA2 | |
| Oxalic Acid SCHEMBL20740005 | 0.95 | LMNA (0.44) | LMNATSHRTDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103959537-A | Mixtures and their use in lithium ion batteries | BASF SE | 2014-07-30 | — | — | CN | claimed |
| US-8404389-B2 | solvent of the electrolytic solution contains a sulfone compound such as or bis(trimethylsilyl)methanedisulfonate or other sulfonate-silane compounds; chemical stability of the electrolytic solution is improved | SONY CORPORATION (JP) | 2013-03-26 | — | — | US | claimed |
| US-8241795-B2 | Electrolytic solutions and battery | SONY CORPORATION (JP) | 2012-08-14 | — | — | US | claimed |
| US-20080138714-A1 | ELECTROLYTIC SOLUTIONS AND BATTERY | SONY CORPORATION (JP) | 2008-06-12 | — | — | US | claimed |
| US-20080138715-A1 | ELECTROLYTIC SOLUTION AND BATTERY | SONY CORPORATION (JP) | 2008-06-12 | — | — | US | claimed |
| WO-2023206925-A1 | LITHIUM-ION BATTERY | 惠州市豪鹏科技有限公司 | 2023-11-02 | — | — | WO | disclosed |
| WO-2023206921-A1 | LITHIUM-ION BATTERY | 惠州市豪鹏科技有限公司 | 2023-11-02 | — | — | WO | disclosed |
| CN-103988355-A | Electrochemical cells and the use thereof | BASF SE | 2014-08-13 | — | — | CN | disclosed |
| CN-103959537-A | Mixtures and their use in lithium ion batteries | BASF SE | 2014-07-30 | — | — | CN | disclosed |
| US-8652682-B2 | Ionic compound, electrolytic solution, electrochemical device, and battery | SONY CORPORATION (JP) | 2014-02-18 | — | — | US | disclosed |
| US-8404389-B2 | solvent of the electrolytic solution contains a sulfone compound such as or bis(trimethylsilyl)methanedisulfonate or other sulfonate-silane compounds; chemical stability of the electrolytic solution is improved | SONY CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| CN-101188314-B | Ionic compound, electrolytic solution, electrochemical device, and battery | SONY CORP | 2012-10-03 | — | — | CN | disclosed |
| US-8241795-B2 | Electrolytic solutions and battery | SONY CORPORATION (JP) | 2012-08-14 | — | — | US | disclosed |
| CN-101197456-B | Electrolyte solution and battery | SONY CORP | 2010-12-29 | — | — | CN | disclosed |
| US-20080138714-A1 | ELECTROLYTIC SOLUTIONS AND BATTERY | SONY CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20080138715-A1 | ELECTROLYTIC SOLUTION AND BATTERY | SONY CORPORATION (JP) | 2008-06-12 | — | — | US | disclosed |
| CN-101197456-A | Electrolyte solution and battery | SONY CORP (JP) | 2008-06-11 | — | — | CN | disclosed |
| CN-101188314-A | Ionic compound, electrolytic solution, electrochemical device, and battery | SONY CORP (JP) | 2008-05-28 | — | — | CN | disclosed |
| US-20080118845-A1 | IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY | SONY CORPORATION (JP) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080118845-A1 | IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY | CA2, DUOX2, OTC | LMNA 3285/4885TSHR 2127/4885TDP1 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.